Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-24-000320

Options or other derivatives

  • Chief Legal Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

VARKI PAUL · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X05/primary_doc.xml…